Pharma & Biotech

Pharmaceutical giant Bristol-Myers Squibb is navigating turbulent waters as it implements an unconventional approach to maintain its market position. With...

The gene editing sector is witnessing remarkable developments as Intellia Therapeutics demonstrates groundbreaking progress with its CRISPR-based therapies. Within a...

Biopharmaceutical company Axsome Therapeutics has moved to resolve significant legal challenges through a proposed $7.75 million settlement agreement. This development...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover...

Assembly Biosciences shares extended their decline for a third consecutive session, closing Thursday's trading at $24.67 after shedding 3.37% of...

aTyr Pharma's stock faced another challenging session on Friday, declining nearly 6% to close at $0.841 per share. The biotech...

The biotechnology landscape is undergoing significant transformation, and BioNTech appears strategically positioned for this new era. As major pharmaceutical companies...

The recent trading activity for India Globalization Capital (IGC Pharma) presents a classic case of biotech volatility. Despite announcing significant...

Celularity Inc. witnessed a dramatic trading session on Friday, with its stock price climbing 10.29% to close at $2.25. This...